Search Articles

View query in Help articles search

Search Results (1 to 10 of 1866 Results)

Download search results: CSV END BibTex RIS


Support of Home-Based Structured Walking Training and Prediction of the 6-Minute Walk Test Distance in Patients With Peripheral Arterial Disease Based on Telehealth Data: Prospective Cohort Study

Support of Home-Based Structured Walking Training and Prediction of the 6-Minute Walk Test Distance in Patients With Peripheral Arterial Disease Based on Telehealth Data: Prospective Cohort Study

While medication is also recommended throughout stages III and IV, SWT is only prescribed in stages II and III. Stages III and IV have surgical interventions as an additional treatment option [3,4]. SWT can more than double the pain-free walking distance of patients with peripheral arterial disease within a 12-week program [6,7], and achieve long-term outcomes comparable to surgical intervention (revascularization) while being less expensive and non-invasive [4,8].

Fabian Wiesmüller, Andreas Prenner, Andreas Ziegl, Gihan El-Moazen, Robert Modre-Osprian, Martin Baumgartner, Marianne Brodmann, Gerald Seinost, Günther Silbernagel, Günter Schreier, Dieter Hayn

JMIR Form Res 2025;9:e65721

Improving Phenotyping of Patients With Immune-Mediated Inflammatory Diseases Through Automated Processing of Discharge Summaries: Multicenter Cohort Study

Improving Phenotyping of Patients With Immune-Mediated Inflammatory Diseases Through Automated Processing of Discharge Summaries: Multicenter Cohort Study

Classification criteria are also based on specific autoantibodies, including anti-Scl-70, anticentromere, and anti-RNA polymerase III, which we have chosen to analyze here [41]. Therapeutic management is also based on glucocorticoids and immunosuppressive drugs, such as mycophenolate mofetil.

Adam Remaki, Jacques Ung, Pierre Pages, Perceval Wajsburt, Elise Liu, Guillaume Faure, Thomas Petit-Jean, Xavier Tannier, Christel Gérardin

JMIR Med Inform 2025;13:e68704